Crispina Calsada Regulus Therapeutics Inc. (RGLS) insider trading activity

RGLS Quotes by TradingView

Crispina Calsada is Chief Financial Officer of Regulus Therapeutics Inc.. Currently has a direct ownership of 0 shares of RGLS, which is worth approximately $0. The most recent transaction as insider was on Jun 25, 2025, when has been sold 140,228 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

CRISPINA CALSADA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2025
SELL
Sale (or disposition) back to the issuer
-
140,228 Reduced 100.0%
0 Common Stock
Jan 14 2025
SELL
Open market or private sale
$6,410 $1.26 p/Share
5,088 Reduced 10.06%
45,478 Common Stock
Jan 13 2025
SELL
Open market or private sale
$48,782 $1.26 p/Share
38,716 Reduced 43.36%
50,566 Common Stock
Jan 09 2025
BUY
Grant, award, or other acquisition
$111,055 $1.33 p/Share
83,500 Added 48.33%
89,282 Common Stock
Jan 18 2024
SELL
Open market or private sale
$6,506 $1.19 p/Share
5,468 Reduced 48.6%
5,782 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
11,250 Added 50.0%
11,250 Common Stock
CC

Crispina Calsada

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on RGLS

Follow Regulus Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGLS shares.

Notify only if

Insider Trading

Get notified when an Regulus Therapeutics Inc. insider buys or sells RGLS shares.

Notify only if

News

Receive news related to Regulus Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGLS